Young Onset Parkinson's Disease: A Modern and Tailored Approach.
Parkinsons’s disease
caregiver
dystonia
genetics
quality of life
work
young-onset
Journal
Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
12
7
2020
medline:
9
10
2021
entrez:
12
7
2020
Statut:
ppublish
Résumé
In people with young onset Parkinson's disease (YOPD), onset of symptoms is between 21 and 40 years of age. The distinction between YOPD and late-onset Parkinson's disease is supported by genetic differences (a genetic etiology is more common in people with YOPD) and clinical differences (e.g., dystonia and levodopa-induced dyskinesias are more common inYOPD). Moreover, people with YOPD tend to have different family and societal engagements compared to those with late-onset PD. These unique features have implications for clinical management, and call for a tailored multidisplinary approach involving shared-decision making.
Identifiants
pubmed: 32651336
pii: JPD202135
doi: 10.3233/JPD-202135
pmc: PMC7592661
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S29-S36Références
Disabil Rehabil. 2006 Jan 15;28(1):13-24
pubmed: 16393829
Parkinsonism Relat Disord. 2009 Feb;15(2):153-5
pubmed: 18514013
Neurology. 2009 Jan 13;72(2):110-6
pubmed: 18987353
Lancet Neurol. 2020 May;19(5):452-461
pubmed: 32171387
Front Neurol. 2015 Sep 01;6:191
pubmed: 26388833
Lancet. 2004 May 29;363(9423):1783-93
pubmed: 15172778
Parkinsonism Relat Disord. 2019 Aug;65:39-48
pubmed: 31176633
Neurology. 1993 Jun;43(6):1150-8
pubmed: 8170560
Neurology. 1991 Feb;41(2 ( Pt 1)):168-73
pubmed: 1992358
Mov Disord. 2018 Dec;33(12):1857-1870
pubmed: 30357936
Lancet. 1975 Sep 27;2(7935):607
pubmed: 51431
Neurology. 2018 Dec 11;91(24):e2238-e2243
pubmed: 30404780
N Engl J Med. 2019 Jan 24;380(4):315-324
pubmed: 30673543
Mov Disord. 2006 Nov;21(11):1839-43
pubmed: 16941456
Mov Disord. 2011 Sep;26(11):2011-8
pubmed: 21574185
Ir J Med Sci. 2013 Sep;182(3):415-9
pubmed: 23325501
Mov Disord. 2010 Jul 15;25(9):1279-84
pubmed: 20629119
Mov Disord. 2014 Nov;29(13):1583-90
pubmed: 24976103
Mov Disord. 2016 Apr;31(4):436-57
pubmed: 27079681
Ann Neurol. 2018 Dec;84(6):797-811
pubmed: 30357892
Mov Disord. 2003 Dec;18(12):1545-7
pubmed: 14673897
N Engl J Med. 2013 Feb 14;368(7):610-22
pubmed: 23406026
J Neurol. 2013 Jan;260(1):131-7
pubmed: 22820720
Neurology. 1991 Feb;41(2 ( Pt 1)):202-5
pubmed: 1992362
Neurology. 1990 Oct;40(10):1529-34
pubmed: 2215943
Mov Disord Clin Pract. 2020 Apr 09;7(4):419-430
pubmed: 32373659
Neurology. 1998 Jun;50(6):1920-1
pubmed: 9633767
Mov Disord. 2003 Nov;18(11):1250-6
pubmed: 14639664
Disabil Rehabil. 2018 Aug;40(17):2032-2039
pubmed: 28486826
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Lancet Neurol. 2020 Feb;19(2):170-178
pubmed: 31521533
BMC Neurosci. 2016 Feb 01;17:6
pubmed: 26831335
Mov Disord. 2019 Feb;34(2):180-198
pubmed: 30653247
Mov Disord. 2010 May 15;25(7):838-45
pubmed: 20461800
Genet Couns. 2001;12(1):55-67
pubmed: 11332979
Brain. 2006 Apr;129(Pt 4):1050-8
pubmed: 16476675
J Parkinsons Dis. 2017;7(4):635-644
pubmed: 28777757
Lancet Neurol. 2006 Apr;5(4):355-63
pubmed: 16545752
J Genet Couns. 2011 Aug;20(4):384-95
pubmed: 21476119
Mov Disord. 1987;2(2):73-91
pubmed: 3504266
Lancet Neurol. 2018 Jun;17(6):559-568
pubmed: 29699914
Parkinsonism Relat Disord. 2017 Jul;40:11-17
pubmed: 28506531
Pract Neurol. 2011 Jun;11(3):145-52
pubmed: 21551108
Lancet. 2014 Sep 27;384(9949):1196-205
pubmed: 24928805
Mov Disord. 2018 Aug;33(8):1248-1266
pubmed: 29570866
Eur J Neurol. 2013 Jan;20(1):5-15
pubmed: 23279439
JAMA Neurol. 2017 Jun 1;74(6):633-634
pubmed: 28459962
Parkinsonism Relat Disord. 2014 May;20(5):530-4
pubmed: 24631501
Brain. 2020 Mar 1;143(3):751-770
pubmed: 31800013
Arch Neurol. 2010 May;67(5):589-95
pubmed: 20457959
Mov Disord. 2011 Feb 15;26(3):457-63
pubmed: 21229621
Mov Disord. 2013 Jul;28(8):1064-71
pubmed: 23630119